Rhythm on a chip: circadian entrainment in vitro is the next frontier in body-on-a chip technology

J.-M. Fustin, M. Li, B. Gao, Q. Chen, T. Cheng, A.G. Stewart

Research output: Contribution to journalArticlepeer-review

Abstract

Organoids, bioprinted mini-tissues and body-on-a-chip technologies are poised to transform the practice of preclinical pharmacology, with a view to achieving better predictive value. We review the need for further refinement in static and dynamic biomechanical aspects of such microenvironments. Further consideration of the developments required in perfusion systems to enable delivery of an appropriate soluble microenvironment are argued. We place particular emphasis on a major deficiency in these systems, being the absence or aberrant circadian behaviour of cells used in such settings, and consider the technical challenges that are needing to be met in order to achieve rhythm-on-a-chip.
Original languageEnglish
JournalCurrent opinion in pharmacology
Early online date7 Oct 2019
DOIs
Publication statusPublished - 2019

Fingerprint

Dive into the research topics of 'Rhythm on a chip: circadian entrainment in vitro is the next frontier in body-on-a chip technology'. Together they form a unique fingerprint.

Cite this